Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Healthcare Triangle (HCTI) EBITDA Margin (2020 - 2025)

Healthcare Triangle's EBITDA Margin history spans 6 years, with the latest figure at 74.18% for Q3 2025.

  • For Q3 2025, EBITDA Margin fell 2242.0% year-over-year to 74.18%; the TTM value through Sep 2025 reached 44.87%, down 1077.0%, while the annual FY2024 figure was 40.35%, 1732.0% down from the prior year.
  • EBITDA Margin for Q3 2025 was 74.18% at Healthcare Triangle, down from 38.19% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 4.67% in Q2 2021 and bottomed at 94.24% in Q4 2022.
  • The 5-year median for EBITDA Margin is 21.91% (2021), against an average of 31.87%.
  • The largest annual shift saw EBITDA Margin tumbled -5806bps in 2022 before it soared 7538bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 36.18% in 2021, then crashed by -160bps to 94.24% in 2022, then skyrocketed by 80bps to 18.87% in 2023, then decreased by -14bps to 21.6% in 2024, then crashed by -243bps to 74.18% in 2025.
  • Per Business Quant, the three most recent readings for HCTI's EBITDA Margin are 74.18% (Q3 2025), 38.19% (Q2 2025), and 37.42% (Q1 2025).